North Carolina SB 265: Increase Municipal Election Participation Act.

Bill Text

GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2025
S 1
SENATE BILL 265

Short Title: Protecting Our Community Act. (Public)
Sponsors: Senators Johnson, Britt, and Lazzara (Primary Sponsors).
Referred to: Rules and Operations of the Senate
March 12, 2025
*S265-v-1*
A BILL TO BE ENTITLED 1
AN ACT TO REGULATE THE SALE AND DISTRIBUTION OF HEMP-DERIVED 2
CONSUMABLE PRODUCTS AND TO BAN THOSE PRODUCTS FROM SCHOOL 3
GROUNDS. 4
The General Assembly of North Carolina enacts: 5
6
PART I. REGULATION OF HEMP-DERIVED CONSUMABLE PRODUCTS 7
SECTION 1.(a) The General Statutes are amended by adding a new Chapter to read: 8
"Chapter 18D. 9
"Regulation of Hemp-Derived Consumable Products. 10
"Article 1. 11
"Regulation of Hemp-Derived Consumable Products. 12
"§ 18D-100. Definitions. 13
Unless the context requires otherwise, the following definitions apply in this Article: 14
(1) ALE Division. – As defined in G.S. 18B-101. 15
(2) Batch. – The hemp-derived consumable product produced during a period of 16
time under similar conditions and identified by a specific code that allows 17
traceability. 18
(3) Department. – The Department of Revenue. 19
(4) Distributor. – A person or entity that delivers or sells hemp-derived 20
consumable products for the purpose of distribution in commerce. 21
(5) Exit package. – An opaque bag or other similar opaque covering provided at 22
the point of sale that satisfies the child-resistant effectiveness standards under 23
16 C.F.R. § 1700.15(b)(1) when tested in accordance with the requirements 24
of 16 C.F.R. § 1700.20 in which hemp-derived consumable products are 25
placed by a seller after being sold to the ultimate consumer of the product. 26
(6) Final form product. – A product intended for consumer use and to be sold by 27
a seller. 28
(7) Hemp. – As defined in G.S. 90-87. 29
(8) Hemp-derived cannabinoid. – Any phytocannabinoid found in hemp, 30
including delta-9 tetrahydrocannabinol (delta-9 THC), tetrahydrocannabinolic 31
acid (THCA), cannabidiol (CBD), cannabidiolic acid (CBDA), cannabinol 32
(CBN), cannabigerol (CBG), cannabichromene (CBC), cannabicyclol (CBL), 33
cannabivarin (CBV), tetrahydrocannabivarin (THCV), cannabidivarin 34
(CBDV), cannabicitran (CBT), delta-7 tetrahydrocannabinol (delta-7 THC), 35
delta-8 tetrahydrocannibinol (delta-8 THC), or delta-10 tetrahydrocannibinol 36

General Assembly Of North Carolina Session 2025
Page 2 Senate Bill 265-First Edition
(delta-10 THC). This term also includes any synthetic cannabinoid derived 1
from hemp and contained in a hemp-derived consumable product. 2
(9) Hemp-derived consumable product. – A final form hemp product that is 3
intended for human ingestion or inhalation that contains a delta-9 THC 4
concentration of not more than three-tenths of one percent (0.3%) on a dry 5
weight basis, but may contain concentrations of other hemp-derived 6
cannabinoids, in excess of that amount. This term does not include hemp 7
products intended for topical application or seeds or seed-derived ingredients 8
that are generally recognized as safe by the United States Food and Drug 9
Administration (FDA). 10
(10) Hemp product. – As defined in G.S. 90-87. 11
(11) Independent testing laboratory. – A laboratory that meets all of the following 12
conditions: 13
a. Holds an ISO 17025 or equivalent accreditation or is registered with 14
the Drug Enforcement Administration (DEA) in accordance with 21 15
C.F.R. § 1301.13. 16
b. Does not have a direct or indirect interest in the entity whose product 17
is being tested. 18
c. Does not have a direct or indirect interest in a facility that cultivates, 19
processes, distributes, dispenses, or sells hemp-derived consumable 20
products in this State or any other jurisdiction. 21
d. Has entered into a compliance agreement with the ALE Division to 22
conduct tetrahydrocannabinol concentration sampling and testing 23
using the high-performance liquid chromatography (HPLC) or a fit for 24
purpose and validated testing method. 25
(12) Ingestion. – The process of consuming hemp through the mouth, by 26
swallowing into the gastrointestinal system or through tissue absorption. 27
(13) Inhalation. – The process of consuming hemp into the respiratory system 28
through the mouth or nasal passages. 29
(14) License. – A license issued in accordance with this Chapter. 30
(15) Manufacture. – To compound, blend, extract, infuse, cook, or otherwise 31
manipulate hemp or a hemp-derived cannabinoid to make, prepare, or package 32
hemp-derived consumable products. 33
(16) Manufacturer. – Any person or entity who, at a commercial establishment, 34
engages in the process of manufacturing, preparing, or packaging of 35
hemp-derived consumable products. 36
(17) Producer. – Any person or entity that engages in the process of farming and 37
harvesting hemp that is intended to be used in the manufacture of a 38
hemp-derived consumable product. 39
(18) Raw hemp extract. – Hemp extract not intended for consumer use. 40
(19) Seller. – Any person who